Valuation: Life Science REIT plc

Capitalization 142M 191M 163M 150M 263M 17.86B 270M 1.76B 692M 8.53B 716M 700M 30.46B P/E ratio 2023
-10.2x
P/E ratio 2024 -9.5x
Enterprise value 142M 191M 163M 150M 263M 17.86B 270M 1.76B 692M 8.53B 716M 700M 30.46B EV / Sales 2023
16,028,992x
EV / Sales 2024 9,236,119x
Free-Float
92.89%
Yield 2023
6.33%
Yield 2024 5.26%
1 day+0.99%
1 week+4.60%
Current month+4.87%
1 month+2.00%
3 months+9.65%
6 months+7.92%
Current year+3.81%
1 week 39.21
Extreme 39.214
41.8
1 month 37.2
Extreme 37.2
41.8
Current year 34
Extreme 34
44.3
1 year 34
Extreme 34
49
3 years 31.3
Extreme 31.3
77.4
5 years 31.3
Extreme 31.3
106
10 years 31.3
Extreme 31.3
106
Manager TitleAgeSince
Investor Relations Contact - 2023-03-31
Human Resources Officer - -
Director TitleAgeSince
Chairman 58 2021-10-31
Director/Board Member 64 2021-10-13
Director/Board Member 65 2021-10-13
Change 5d. change 1-year change 3-years change Capi.($)
+0.99%+4.60%-6.19%-36.29% 191M
+0.61%+1.90%-14.93%+0.62% 23.56B
+0.86%+1.88%-8.34%+2.17% 22.95B
+0.86%+1.29%-7.76%+20.95% 16.05B
+0.15%+2.26%+5.39%-4.94% 15.96B
+1.37%+2.71%-19.53%-18.28% 15.56B
+0.61%+1.99%-19.98%-13.80% 14.65B
+0.14%+1.50%-1.73%+1.07% 12.47B
+1.02%+1.34%-13.77%-12.54% 11.32B
+0.97%+2.66%-16.22%-7.28% 10.82B
Average +0.75%+1.28%-10.31%-6.83% 14.35B
Weighted average by Cap. +0.72%+1.33%-10.68%-2.64%

Financials

2023 2024
Net sales 19.94M 26.83M 22.92M 21.13M 37.06M 2.51B 38M 248M 97.31M 1.2B 101M 98.54M 4.29B 20.31M 27.32M 23.34M 21.52M 37.74M 2.56B 38.7M 252M 99.1M 1.22B 103M 100M 4.36B
Net income -21.71M -29.2M -24.95M -23M -40.34M -2.73B -41.36M -269M -106M -1.31B -110M -107M -4.66B -13.98M -18.8M -16.06M -14.81M -25.97M -1.76B -26.63M -173M -68.2M -841M -70.56M -69.07M -3B
Net Debt 93.58 125.89 107.54 99.16 173.89 11.79K 178.31 1.16K 456.62 5.63K 472.44 462.42 20.11K 116.67 156.95 134.09 123.63 216.81 14.7K 222.31 1.45K 569.31 7.02K 589.03 576.54 25.07K
Logo Life Science REIT plc
Life Science REIT plc is a closed-ended real estate investment trust. The Company’s investment objective is to provide shareholders with an attractive level of total return. It seeks to invests in a diversified portfolio of properties across the United Kingdom, which are typically leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. It acquires or develops properties, such as wet and dry laboratories, offices, incubators and co-working space, manufacturing and testing facilities and data centers. The Company retains flexibility to acquire individual buildings, a group of buildings across a single science park or the entirety of a science park. It also includes purchasing or developing buildings that are leased or intended to be leased to occupiers providing ancillary services to employees of companies operating in, or providing a benefit to, the life science sector. Its investment adviser is Ironstone Asset Management Limited.
Employees
-
Date Price Change Volume
26-04-14 40.90 p +0.99% 660,458
26-04-13 40.50 p -2.88% 83,908
26-04-10 41.70 p +3.22% 313,805
26-04-09 40.40 p -0.98% 360,671
26-04-08 40.80 p +4.35% 239,366
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.4050GBP
Average target price
0.3700GBP
Spread / Average Target
-8.64%

Annual profits - Rate of surprise